Intercollegiate Committee on Haematology

The Intercollegiate Committee on Haematology (ICCH) is established between The Royal College of Pathologists and The Royal College of Physicians (London) and provides essential links between both Colleges and the specialist societies – the British Society for Haematology, Association of Clinical Pathologists and other colleges through the Joint Collegiate Council on Oncology.

Administration of the ICH is divided between the Royal College of Physicians (London) and the Royal College of Pathologists on a three-yearly basis. The committee reports to the councils of both colleges. The Royal College of Physicians resumed responsibility for administering the committee in January 2025.

Chair: Vacant

Committee Members

Ms Katy Amberley - Chief Executive, British Society for Haematology
Joanne Brinklow - Director of Learning
Dr Subarna Chakravorty - Haemaglobinopathies CRG Representative
Dr Sarah Clarke - (President, RCP)
Dr Cathryn Edwards - RCP Registrar
Dr Mark Ethell - Chair of Haematology SAC
Dr Dora Foukaneli - FRCPath Part 2 Exam Lead
Dr Keith Gomez - NQAAP in Haematology, Chair
Mr Jon Hossain - Postgraduate Dean for Haematology
Dr Shruthi Narayan - Chair of Transfusion Medicine SAC
Dr Roderick Neilson - Royal College of Physicians and Surgeons of Glasgow
Professor Eduardo Olavarrio - BSBMTCT President, Haematopathology
Dr Deepti Radia - Lead examiner for haematology, RCPath
Dr Anne Rigg - Chemotherapy CRG Representative
Dr Susie Shapiro - Specialist Blood Disorder CRG Representative
Dr Kate Talks - RCP Haematology SAC, JRCPTB
Dr Polly Talley - Clinical Scientist Representative
Dr Chris Tiplady - RCPath representative (Medically qualified)
Dr Dana Warcel - Haematology Trainee Representative
Dr Rob Webster - Association of Clinical Pathologists (ACP) Lead
Dr Marion Wood - Getting it Right First Time representative
Dr Josh Wright - British Society for Haematology, President
Dr Jiexin Zheng - Haematology Trainee Representative

Celebrating our specialties

Discover more about ongoing developments and key achievements in haematology in our Bulletin articles.

Chronic myeloid leukaemia: a paradigm shift in diagnosis and treatment

Harry Robertson and Jane Apperley introduce the story of chronic myeloid leukaemia, with a history that stands as an exemplar for the remarkable advances that can be achieved through close collaboration between pathologists, clinicians and the pharmaceutical industry.
Thrombotic thrombocytopenic purpura: past, present and future

Thrombotic thrombocytopenic purpura is a rare disorder associated with microvascular thrombi. Here, Marie Scully and John-Paul Westwood describe progress in understanding the pathophysiology supporting prompt diagnosis and the development of novel therapies towards improving patient outcomes.
Haemophilia and gene therapy

Alan Mitchell and Priyanka Raheja explore the development of the haemophilia treatments, looking to a future where gene therapy may revolutionise the treatment landscape.